2005, Number 5
<< Back Next >>
Rev Mex Urol 2005; 65 (5)
Ethanol transuretral ablation of the prostate (ATPE) in patients with urinary retention
Fonseca RR, Gutiérrez AJ, Hurtad OF, Nishimura TS, Magaña GA
Language: Spanish
References: 8
Page: 328-330
PDF size: 48.11 Kb.
ABSTRACT
We are presenting a clinical research with the purpose of evaluation of outcome in patients with urinary retention secondary to benign prostatic hyperplasia treated with transurethral chemo-ablation of the prostate with ethanol. Using the Prostaject TM, device, an initial cohort of 15 patients were treated with this alternative technique and evaluated with IPSS and residual urine volume 3 months postoperatively. Results were satisfactory in 93% of the patients obtaining a moderated IPSS in average.
REFERENCES
Ditrolio J, Patel P, Watson RA. Chemoablation of the prostate with dehydratated alcohol for the treatment of prostatic obstruction. J Urol 2002; 167(5): 2100-4.
Talwar GL, Pande SK. Injection treatment for enlarged prostate. Br J Surg 1966; 53: 421.
Angell JC. Treatment of benign prostatic hypertrophy by phenol inyection. Br J Urol; 3 141: 735.
Harmon WJ, Barrett DM, et al. Transurethral enzymatic ablation of the prostate: canine model. Urology 1996; 48: 229.
Zvara P, Karpman E, Stoppacher R, et al. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology 1999; 54: 411.
Zvara P, Li C, Karpman, et al. Prostate chemoablation with transurethral ethanol injection: experimental study. Endoskopie 2000; 9: 43.
Goya N, Ishikawa N, et al. Ethanol injection therapy of the prostate for benign prostatic hiperplasia: preliminary report on application of a new technique.
Watson RA, Patel P, Ditrolio JV. Transurethral ethanol ablation of the prostate. J Urol 2000; 163: 552.
Full text